FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade)
Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and ...
CIDRAP4h
Study estimates current Moderna vaccine 53% effective against COVID hospitalization
A preprint study posted late last week on the server medRxiv reveals that the current Moderna COVID-19 vaccine is 53% ...
S&P 500 Gains and Losses Today: Moderna Stock Plunges After Resignation of FDA Vaccine Official
The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of ...
BioPharma Dive7h
FDA official’s ouster sends shares of vaccine makers sliding
Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...
5MRNA : Moderna's Options Frenzy: What You Need to Know
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...
New FDA commissioner agreed to oust top vaccine regulator after private swearing in
Food and Drug Administration Commissioner Marty Makary signed off on the ouster of top vaccine official Peter Marks shortly ...
Explore more
Why Moderna Stock Is Plummeting Today
Shares of Moderna (NASDAQ: MRNA) are falling on Monday. The steep decline comes as the S&P 500 and Nasdaq Composite lost 0.4% and 1.1%, respectively. The vaccine maker's shares tumbled following the ...
Dow Jones Today: Stocks Slide to Extend Selloff as More Tariffs Loom; S&P 500, Nasdaq on Track for Worst Month Since 2022
Stocks were lower in afternoon trading Monday, extending a three-day-losing streak, as investors await announcements on a new ...
Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’
The forced resignation of FDA vaccine regulator Peter Marks has, in part, sparked anxiety in Big Pharma investors, as shares in Moderna and Novavax slide. Marks’ departure comes amid a sweeping ...
Moderna Stock Falls as FDA Vaccine Chief Resigns, Citing RFK Jr.'s 'Misinformation'
Key Takeaways Moderna and other vaccine stocks fell Monday after the Food and Drug Administration's vaccine chief, Peter ...
The Pharma Letter10h
TGA approval for Moderna RSV vaccine for older adults
Australian medicines regulator, the Therapeutic Goods Administration (TGA), has granted approval for mRESVIA (mRNA-1345), an ...
Moderna, Novavax Shares Are Tumbling Monday: What's Going On?
Moderna Inc MRNA -11.5% Get Free Report shares were down 13.5% at $26.88 and Novavax Inc NVAX -9.02% Get Free Report shares ...